JeanMarie Guenot Targets New Cancer Treatments Through Amphivena Therapeutics

 

Career

 

 

Jeanmarie Guenot, PhD. is a business administrator in the pharmaceutical and biotechnology industry. She has over 20 years’ experience in the industry. She has worked at the different stages in various companies. She has worked in pharmaceutical research and development, business capital, and venture capital among others. Furthermore, LinkedIn outlines Guenot has worked in the main therapeutic areas like ophthalmology.

 

 

She started her career at Atlas Ventures. Her job involved managing working capital investments and organizations of built life science. Her scientific career began at Hoffmann-La Roche as principal scientist.

 

 

Guenot joined the University of California for her Ph.D. studies. She earned her MBA from the University of Pennsylvania. She is now the President and CEO of Amphivena Therapeutics, Inc., a company involved in the development of bi-functional antibody therapeutic.

 

 

 

 

Accomplishments of Guenot and Amphivena Therapeutics

 

 

As the president of Amphivena Therapeutics, Guenot led to the signing of an agreement with Janssen Biotech, Inc. Through this agreement, Jeanmarie Guenot has been able to select a candidate to assist in the development of treatment for hematologic malignancies.

 

 

Amphivena Therapeutics is working hard to eradicate cancer. This will be achieved through the reestablishment of cellular balance. Guenot brings with her experience in rebuilding.

 

 

Also, Guenot has played a major role in the development of treatment for acute myeloid leukemia.

 

 

 

Guenot Biggest Accomplishments. Which ones most appeal to you?

 

 

  • She has discovered and developed several drugs.
  • She has contributed positively in an area like cardiovascular diseases and neurology among others.
  • She has established companies.
  • She has participated in the merger and acquisition settlement for PDL’s R&D.

 

One accomplishment that appeals to me most is the discovery drugs because it has helped many patients.  All of which is outlined on http://jeanmarieguenot.com/

 

 

Media outlets that have featured Guenot

 

 

  • Business Wire
  • Market Wired
  • MedReps

 

Advantages of utilizing Guenot’s services

 

 

  • She assists biotechnology and pharmaceutical companies by providing consultation services related to project management, merger and acquisition, and licensing among others.
  • Her discovery and development of new drugs have played a major role in the development of human life.

 

Guenot’s social media

 

 

JeanMarie Guenot has a Facebook account. She shares the summary of what she has done. She also shares information on places and ranks she has previously occupied.

 

 

 

Guenot’s business model and her role in the community

 

 

Guenot’s business model is based on building partnerships. She works towards invention and development of new drugs and treatment methods. She has contributed to the improvement of human life by developing new treatment methods.She has helped Amphivena Therapeutics make progress in developing different treatment procedures for cancer.She has also helped biotechnology and pharmaceutical companies meet their financial needs by providing them with her skills and experience.

Leave a Reply